Base de dados : MEDLINE
Pesquisa : E02.148.224 [Categoria DeCS]
Referências encontradas : 7835 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 784 ir para página                         

  1 / 7835 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29293200
[Au] Autor:de Freitas Floriano CM; Machado Avelar AF; Sorgini Peterlini MA
[Ad] Endereço:Escola Paulista de Enfermagem, Universidade Federal de São Paulo, São Paulo, Brazil (Drs Machado Avelar and Sorgini Peterlini and Ms de Freitas Floriano). Claudia Maria de Freitas Floriano, MSc, is a pediatric emergency nurse at the Escola Paulista de Enfermagem of the Universidade Federal de São Paulo, in São Paulo, Brazil. Ariane Ferreira Machado Avelar, PhD, MSc, RN, is an adjunct professor at the Escola Paulista de Enfermagem of the Universidade Federal de São Paulo in São Paulo, Brazil. Maria Angélica Sorgini Peterlini, PhD, MSc, RN, is an associate professor at the Escola Paulista de Enfermagem of the Universidade Federal de São Paulo in São Paulo, Brazil.
[Ti] Título:Difficulties Related to Peripheral Intravenous Access in Children in an Emergency Room.
[So] Source:J Infus Nurs;41(1):66-72, 2018 Jan/Feb.
[Is] ISSN:1539-0667
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:This prospective study examined the characteristics of children admitted to a pediatric emergency department and the factors that influenced the successful establishment of peripheral intravenous (IV) access. Descriptive and correlational analysis was completed using a convenience sample of 89 patients. Peripheral IV access was successful in 95.7% of the children, and the first attempt at insertion was successful in 53% of the procedures. Factors influencing the success of peripheral IV access were the patient's gender, skin color, presence of difficult-to-see veins, small veins, presence of fever, and a lack of palpable veins.
[Mh] Termos MeSH primário: Cateterismo Periférico/efeitos adversos
Serviço Hospitalar de Emergência
Veias/anormalidades
[Mh] Termos MeSH secundário: Administração Intravenosa/métodos
Adolescente
Fatores Etários
Cateterismo Periférico/instrumentação
Criança
Pré-Escolar
Grupos de Populações Continentais
Feminino
Seres Humanos
Lactente
Recém-Nascido
Infusões Intravenosas/instrumentação
Masculino
Estudos Prospectivos
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1803
[Cu] Atualização por classe:180305
[Lr] Data última revisão:
180305
[Sb] Subgrupo de revista:N
[Da] Data de entrada para processamento:180103
[St] Status:MEDLINE
[do] DOI:10.1097/NAN.0000000000000262


  2 / 7835 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28460768
[Au] Autor:Nanjappa V; Sadanand KS; Santhosh K; Basappa H; Manjunath CN; Nayak MH
[Ad] Endereço:Sri Jayadeva Institute of Cardiovascular Sciences and Research, Mysore, India. Electronic address: veenananjappa@yahoo.co.in.
[Ti] Título:Case series: Difficult PTMC using novel technique of veno-arterial looping.
[So] Source:Indian Heart J;69(2):207-210, 2017 Mar - Apr.
[Is] ISSN:0019-4832
[Cp] País de publicação:India
[La] Idioma:eng
[Ab] Resumo:Percutaneous transvenous mitral commissurotomy (PTMC) using Inoue/Accura balloon is an effective procedure for management of patients with rheumatic mitral stenosis. Inability to cross the mitral valve is one of the pertinent reasons for procedural failure. We describe a series of three patients who were tackled with successful PTMC using a novel technique of veno-arterial looping and in the fourth patient we used double loop entry into left ventricle with veno-arterial rail and peripheral balloon dilatation for completing the PTMC. This is first such reported case series in literature to our knowledge.
[Mh] Termos MeSH primário: Valvuloplastia com Balão/métodos
Cateterismo Cardíaco/métodos
Cateterismo Periférico/métodos
Estenose da Valva Mitral/cirurgia
Valva Mitral/cirurgia
Cirurgia Assistida por Computador/métodos
[Mh] Termos MeSH secundário: Adulto
Artérias
Feminino
Fluoroscopia
Seres Humanos
Meia-Idade
Estenose da Valva Mitral/diagnóstico
Veias
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180301
[Lr] Data última revisão:
180301
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170503
[St] Status:MEDLINE


  3 / 7835 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29390474
[Au] Autor:Liu B; Sun W; Wang K
[Ad] Endereço:Department of Parenteral and Enteral Nutrition, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
[Ti] Título:A successful insertion of PICC in patient with cardiac angiosarcoma and neoplasty of right atrium and pacemaker: A case report.
[So] Source:Medicine (Baltimore);96(51):e9225, 2017 Dec.
[Is] ISSN:1536-5964
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:INTRODUCTION: Primary cardiac angiosarcoma is a rare tumor and the common treatment is surgical resection followed by chemotherapy. Peripherally inserted central venous catheters (PICCs) are widely used in cancer patients and ultrasound-guided PICC insertion could improve success rate especially in patient with abnormal anatomy structure. Reports about PICCs being placed in patient who had suffered from the cardiac angiosarcoma and neoplasty of right atrium with an ipsilateral cardiac permanent pacemaker are rarely.After patient's informed consent, we present a case of the successful insertion of PICC into a patient with the ipsilateral cardiac disease with a pacemaker placement, which has not been previously reported. CONCLUSIONS: This report highlights PICC could be used in patient with cardiac disease with a pacemaker placement for chemotherapy.
[Mh] Termos MeSH primário: Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem
Cateterismo Periférico/métodos
Cateteres Venosos Centrais
Neoplasias Cardíacas/terapia
Hemangiossarcoma/terapia
Marca-Passo Artificial
[Mh] Termos MeSH secundário: Terapia Combinada
Feminino
Seguimentos
Átrios do Coração/efeitos dos fármacos
Neoplasias Cardíacas/diagnóstico
Hemangiossarcoma/diagnóstico
Seres Humanos
Infusões Intralesionais
Meia-Idade
Doenças Raras
Resultado do Tratamento
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180214
[Lr] Data última revisão:
180214
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:180203
[St] Status:MEDLINE
[do] DOI:10.1097/MD.0000000000009225


  4 / 7835 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29390472
[Au] Autor:Wang K; Sun W; Shi X
[Ad] Endereço:Department of Parenteral and Enteral Nutrition, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
[Ti] Título:Upper extremity deep vein thrombosis after migration of peripherally inserted central catheter (PICC): A case report.
[So] Source:Medicine (Baltimore);96(51):e9222, 2017 Dec.
[Is] ISSN:1536-5964
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:INTRODUCTION: Peripherally inserted central venous catheters (PICC) are widely used in cancer patients and ultrasound-guided PICC insertion could improve success rate. The tip position of the catheter should be located at the border of lower one-third of the superior vena cava (SVC) and cavo-atrial junction. The migration is malposition at the late stage after PICCs were inserted, and catheter malposition was associated with thrombosis and other complications.After patient's informed consent, we report a case of a 66-year-old male with twice catheter migrations resulting in thrombosis after being diagnosed with cardiac cancer. CONCLUSION: The correct position of the catheter tip can ensure the normal use of PICC and reduce the complications. For the migrated catheter, it should be removed as soon as possible, and when thrombosis has been developed, standard anticoagulant therapy should be given.
[Mh] Termos MeSH primário: Anticoagulantes/administração & dosagem
Cateterismo Periférico/efeitos adversos
Cateteres Venosos Centrais/efeitos adversos
Migração de Corpo Estranho/complicações
Trombose Venosa Profunda de Membros Superiores/etiologia
Trombose Venosa Profunda de Membros Superiores/terapia
[Mh] Termos MeSH secundário: Idoso
Cateterismo Periférico/métodos
Remoção de Dispositivo
Falha de Equipamento
Seguimentos
Migração de Corpo Estranho/diagnóstico por imagem
Neoplasias Cardíacas/diagnóstico
Neoplasias Cardíacas/tratamento farmacológico
Seres Humanos
Masculino
Medição de Risco
Resultado do Tratamento
Ultrassonografia Doppler em Cores/métodos
Trombose Venosa Profunda de Membros Superiores/diagnóstico por imagem
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Anticoagulants)
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180214
[Lr] Data última revisão:
180214
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:180203
[St] Status:MEDLINE
[do] DOI:10.1097/MD.0000000000009222


  5 / 7835 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Registro de Ensaios Clínicos
Registro de Ensaios Clínicos
Texto completo
[PMID]:29211671
[Au] Autor:Vedantham S; Goldhaber SZ; Julian JA; Kahn SR; Jaff MR; Cohen DJ; Magnuson E; Razavi MK; Comerota AJ; Gornik HL; Murphy TP; Lewis L; Duncan JR; Nieters P; Derfler MC; Filion M; Gu CS; Kee S; Schneider J; Saad N; Blinder M; Moll S; Sacks D; Lin J; Rundback J; Garcia M; Razdan R; VanderWoude E; Marques V; Kearon C; ATTRACT Trial Investigators
[Ad] Endereço:From the Washington University School of Medicine, St. Louis (S.V., L.L., J.R.D., P.N., M.C.D., N.S., M.B.); Brigham and Women's Hospital, Harvard Medical School (S.Z.G.), and Massachusetts General Hospital, Harvard Medical School (M.R.J.) - all in Boston; McMaster University, Hamilton, ON (J.A.J.,
[Ti] Título:Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis.
[So] Source:N Engl J Med;377(23):2240-2252, 2017 12 07.
[Is] ISSN:1533-4406
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: The post-thrombotic syndrome frequently develops in patients with proximal deep-vein thrombosis despite treatment with anticoagulant therapy. Pharmacomechanical catheter-directed thrombolysis (hereafter "pharmacomechanical thrombolysis") rapidly removes thrombus and is hypothesized to reduce the risk of the post-thrombotic syndrome. METHODS: We randomly assigned 692 patients with acute proximal deep-vein thrombosis to receive either anticoagulation alone (control group) or anticoagulation plus pharmacomechanical thrombolysis (catheter-mediated or device-mediated intrathrombus delivery of recombinant tissue plasminogen activator and thrombus aspiration or maceration, with or without stenting). The primary outcome was development of the post-thrombotic syndrome between 6 and 24 months of follow-up. RESULTS: Between 6 and 24 months, there was no significant between-group difference in the percentage of patients with the post-thrombotic syndrome (47% in the pharmacomechanical-thrombolysis group and 48% in the control group; risk ratio, 0.96; 95% confidence interval [CI], 0.82 to 1.11; P=0.56). Pharmacomechanical thrombolysis led to more major bleeding events within 10 days (1.7% vs. 0.3% of patients, P=0.049), but no significant difference in recurrent venous thromboembolism was seen over the 24-month follow-up period (12% in the pharmacomechanical-thrombolysis group and 8% in the control group, P=0.09). Moderate-to-severe post-thrombotic syndrome occurred in 18% of patients in the pharmacomechanical-thrombolysis group versus 24% of those in the control group (risk ratio, 0.73; 95% CI, 0.54 to 0.98; P=0.04). Severity scores for the post-thrombotic syndrome were lower in the pharmacomechanical-thrombolysis group than in the control group at 6, 12, 18, and 24 months of follow-up (P<0.01 for the comparison of the Villalta scores at each time point), but the improvement in quality of life from baseline to 24 months did not differ significantly between the treatment groups. CONCLUSIONS: Among patients with acute proximal deep-vein thrombosis, the addition of pharmacomechanical catheter-directed thrombolysis to anticoagulation did not result in a lower risk of the post-thrombotic syndrome but did result in a higher risk of major bleeding. (Funded by the National Heart, Lung, and Blood Institute and others; ATTRACT ClinicalTrials.gov number, NCT00790335 .).
[Mh] Termos MeSH primário: Anticoagulantes/uso terapêutico
Síndrome Pós-Trombótica/prevenção & controle
Terapia Trombolítica/métodos
Ativador de Plasminogênio Tecidual/administração & dosagem
Trombose Venosa/tratamento farmacológico
[Mh] Termos MeSH secundário: Adulto
Anticoagulantes/efeitos adversos
Cateterismo Periférico
Feminino
Hemorragia/etiologia
Seres Humanos
Incidência
Análise de Intenção de Tratamento
Masculino
Meia-Idade
Síndrome Pós-Trombótica/epidemiologia
Síndrome Pós-Trombótica/etiologia
Proteínas Recombinantes/uso terapêutico
Fatores de Risco
Terapia Trombolítica/efeitos adversos
Ativador de Plasminogênio Tecidual/efeitos adversos
Trombose Venosa/complicações
[Pt] Tipo de publicação:CLINICAL TRIAL, PHASE III; JOURNAL ARTICLE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; RESEARCH SUPPORT, N.I.H., EXTRAMURAL; RESEARCH SUPPORT, NON-U.S. GOV'T
[Nm] Nome de substância:
0 (Anticoagulants); 0 (Recombinant Proteins); EC 3.4.21.68 (Tissue Plasminogen Activator)
[Em] Mês de entrada:1712
[Cu] Atualização por classe:180207
[Lr] Data última revisão:
180207
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:171207
[Cl] Clinical Trial:ClinicalTrial
[St] Status:MEDLINE
[do] DOI:10.1056/NEJMoa1615066


  6 / 7835 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:29261251
[Au] Autor:Ray-Barruel G
[Ti] Título:INFECTION PREVENTION: PERIPHERAL INTRAVENOUS CATHETER ASSESSMENT AND CARE.
[So] Source:Aust Nurs Midwifery J;24(8):34, 2017 Mar.
[Is] ISSN:2202-7114
[Cp] País de publicação:Australia
[La] Idioma:eng
[Ab] Resumo:Peripheral intravenous catheters are the most common device in hospital patients, but they do come with infection risks. Awareness of the complications and regular assessment can reduce risks and improve patient outcomes.
[Mh] Termos MeSH primário: Infecções Relacionadas a Cateter/prevenção & controle
Cateterismo Periférico/efeitos adversos
Cateterismo Periférico/enfermagem
[Mh] Termos MeSH secundário: Infecções Relacionadas a Cateter/enfermagem
Seres Humanos
Flebite/diagnóstico
Flebite/etiologia
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1801
[Cu] Atualização por classe:180118
[Lr] Data última revisão:
180118
[Sb] Subgrupo de revista:N
[Da] Data de entrada para processamento:171221
[St] Status:MEDLINE


  7 / 7835 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29190256
[Au] Autor:Romagnoli A; Teeter W; Pasley J; Hu P; Hoehn M; Stein D; Scalea T; Brenner M
[Ad] Endereço:From the Division of Trauma/Critical Care (A.N.R., W.T., J.P., M.H., D.S., T.S., M.B.), RA Cowley Shock Trauma Center, University of Maryland School of Medicine, Baltimore, Maryland; Division of Anesthesiology (P.M.H.), University of Maryland School of Medicine, Baltimore, Maryland; and Division of Vascular Surgery (M.H., M.B.), University of Maryland School of Medicine, Baltimore, Maryland.
[Ti] Título:Time to aortic occlusion: It's all about access.
[So] Source:J Trauma Acute Care Surg;83(6):1161-1164, 2017 Dec.
[Is] ISSN:2163-0763
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:INTRODUCTION: Resuscitative endovascular balloon occlusion of the aorta (REBOA) is a less invasive method of proximal aortic occlusion compared with resuscitative thoracotomy with aortic cross-clamping (RTACC). This study compared time to aortic occlusion with REBOA and RTACC, both including and excluding time required for common femoral artery (CFA) cannulation. METHODS: This was a retrospective, single-institution review of REBOA or RTACC performed between February 2013 and January 2016. Time of skin incision to aortic cross-clamp for RTACC, time required for CFA cannulation by percutaneous and open methods, and time from guide-wire insertion to balloon inflation at Zone 1 for REBOA, were obtained from videographic recordings. RESULTS: Eighteen RTACC and 21 REBOAs were performed. Median (Q1, Q3) time from skin incision to aortic cross-clamping was 317 seconds (227, 551 seconds). Median (Q1, Q3) time from start of arterial access to Zone 1 balloon occlusion was 474 seconds (431, 572 seconds) (vs. RTACC, p = 0.01). All REBOA procedures were performed with the same device. The median time to complete CFA cannulation was 247 seconds (range, 164-343 seconds), with no difference between percutaneous or open procedures (p = 0.07). The median (Q1, Q3) time to aortic occlusion in REBOA once arterial access had been established was 245 seconds (179, 295.5 seconds), which was significantly shorter than RTACC (p = 0.003). CONCLUSIONS: Once CFA access is achieved, time to aortic occlusion is faster with REBOA. Time to aortic occlusion is less than the time required to cannulate the CFA either by percutaneous or open approaches, emphasizing the importance of accurate and expedient CFA access. Resuscitative endovascular balloon occlusion of the aorta may represent a feasible alternative to thoracotomy for aortic occlusion. Time to aortic occlusion will likely decrease with the advent of newer REBOA technology. The rate-limiting portion of REBOA continues to be obtaining CFA access. LEVEL OF EVIDENCE: Therapeutic, level V.
[Mh] Termos MeSH primário: Aorta Torácica/cirurgia
Oclusão com Balão/métodos
Cateterismo Periférico/métodos
Procedimentos Endovasculares/métodos
Hemorragia/terapia
Ressuscitação/métodos
Ferimentos e Lesões/complicações
[Mh] Termos MeSH secundário: Adulto
Feminino
Artéria Femoral
Seguimentos
Hemorragia/etiologia
Seres Humanos
Masculino
Estudos Retrospectivos
Fatores de Tempo
Resultado do Tratamento
Gravação em Vídeo
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1712
[Cu] Atualização por classe:171211
[Lr] Data última revisão:
171211
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:171201
[St] Status:MEDLINE
[do] DOI:10.1097/TA.0000000000001665


  8 / 7835 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29189249
[Au] Autor:Reeves T; Morrison D; Altmiller G
[Ad] Endereço:Turena Reeves is a quality management coordinator and Dolores Morrison is a clinical nurse specialist at Einstein Medical Center Philadelphia. Gerry Altmiller is an associate professor of nursing at the College of New Jersey, Ewing, and a consultant for Einstein Medical Center Philadelphia. Contact author: Dolores Morrison, morrisod@einstein.edu. Reeves and Morrison received an in-house grant from the Albert Einstein Society to implement this quality improvement project. The authors have disclosed no potential conflicts of interest, financial or otherwise.
[Ti] Título:A Nurse-Led Ultrasound-Enhanced Vascular Access Preservation Program.
[So] Source:Am J Nurs;117(12):56-64, 2017 Dec.
[Is] ISSN:1538-7488
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:: Insertion of peripheral iv catheters is a common practice in medical-surgical care settings. The frequency with which attempts are made to insert catheters causes rapid peripheral vessel depletion (a reduction in the number of usable veins), leading to the overuse of unnecessary central line catheters. Reducing central line-associated bloodstream infections is a national health care priority. In this quality improvement report, the authors describe the implementation of a nurse-led vascular access preservation program using ultrasound technology as a method to reduce the use of nonessential peripherally inserted central catheters.
[Mh] Termos MeSH primário: Cateterismo Venoso Central/enfermagem
Cateterismo Periférico/enfermagem
Melhoria de Qualidade
Ultrassonografia de Intervenção
[Mh] Termos MeSH secundário: Seres Humanos
Papel do Profissional de Enfermagem
Sistemas Automatizados de Assistência Junto ao Leito
Padrões de Prática em Enfermagem
Dispositivos de Acesso Vascular
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1712
[Cu] Atualização por classe:171211
[Lr] Data última revisão:
171211
[Sb] Subgrupo de revista:AIM; IM; N
[Da] Data de entrada para processamento:171201
[St] Status:MEDLINE
[do] DOI:10.1097/01.NAJ.0000527490.24610.51


  9 / 7835 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29191323
[Au] Autor:Yoon SH; Schmidt T; Bleiziffer S; Schofer N; Fiorina C; Munoz-Garcia AJ; Yzeiraj E; Amat-Santos IJ; Tchetche D; Jung C; Fujita B; Mangieri A; Deutsch MA; Ubben T; Deuschl F; Kuwata S; De Biase C; Williams T; Dhoble A; Kim WK; Ferrari E; Barbanti M; Vollema EM; Miceli A; Giannini C; Attizzani GF; Kong WKF; Gutierrez-Ibanes E; Jimenez Diaz VA; Wijeysundera HC; Kaneko H; Chakravarty T; Makar M; Sievert H; Hengstenberg C; Prendergast BD; Vincent F; Abdel-Wahab M; Nombela-Franco L; Silaschi M; Tarantini G; Butter C; Ensminger SM; Hildick-Smith D; Petronio AS; Yin WH; De Marco F; Testa L; Van Mieghem NM; Whisenant BK
[Ad] Endereço:Department of Interventional Cardiology, Cedars-Sinai Heart Institute, Los Angeles, California.
[Ti] Título:Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation.
[So] Source:J Am Coll Cardiol;70(22):2752-2763, 2017 Dec 05.
[Is] ISSN:1558-3597
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Limited data exist about safety and efficacy of transcatheter aortic valve replacement (TAVR) in patients with pure native aortic regurgitation (AR). OBJECTIVES: This study sought to compare the outcomes of TAVR with early- and new-generation devices in symptomatic patients with pure native AR. METHODS: From the pure native AR TAVR multicenter registry, procedural and clinical outcomes were assessed according to VARC-2 criteria and compared between early- and new-generation devices. RESULTS: A total of 331 patients with a mean STS score of 6.7 ± 6.7 underwent TAVR. The early- and new-generation devices were used in 119 patients (36.0%) and 212 patients (64.0%), respectively. STS score tended to be lower in the new-generation device group (6.2 ± 6.7 vs. 7.6 ± 6.7; p = 0.08), but transfemoral access was more frequently used in the early-generation device group (87.4% vs. 60.8%; p < 0.001). Compared with the early-generation devices, the new-generation devices were associated with a significantly higher device success rate (81.1% vs. 61.3%; p < 0.001) due to lower rates of second valve implantation (12.7% vs. 24.4%; p = 0.007) and post-procedural AR ≥ moderate (4.2% vs. 18.8%; p < 0.001). There were no significant differences in major 30-day endpoints between the 2 groups. The cumulative rates of all-cause and cardiovascular death at 1-year follow-up were 24.1% and 15.6%, respectively. The 1-year all-cause mortality rate was significantly higher in the patients with post-procedural AR ≥ moderate compared with those with post-procedural AR ≤ mild (46.1% vs. 21.8%; log-rank p = 0.001). On multivariable analysis, post-procedural AR ≥ moderate was independently associated with 1-year all-cause mortality (hazard ratio: 2.85; 95% confidence interval: 1.52 to 5.35; p = 0.001). CONCLUSIONS: Compared with the early-generation devices, TAVR using the new-generation devices was associated with improved procedural outcomes in treating patients with pure native AR. In patients with pure native AR, significant post-procedural AR was independently associated with increased mortality.
[Mh] Termos MeSH primário: Insuficiência da Valva Aórtica
Valva Aórtica/cirurgia
Artéria Femoral/cirurgia
Próteses Valvulares Cardíacas
Complicações Pós-Operatórias
Substituição da Valva Aórtica Transcateter
[Mh] Termos MeSH secundário: Idoso
Idoso de 80 Anos ou mais
Insuficiência da Valva Aórtica/diagnóstico
Insuficiência da Valva Aórtica/mortalidade
Insuficiência da Valva Aórtica/cirurgia
Cateterismo Periférico/métodos
Cateterismo Periférico/estatística & dados numéricos
Feminino
Próteses Valvulares Cardíacas/efeitos adversos
Próteses Valvulares Cardíacas/normas
Seres Humanos
Cooperação Internacional
Masculino
Mortalidade
Avaliação de Processos e Resultados (Cuidados de Saúde)
Complicações Pós-Operatórias/diagnóstico
Complicações Pós-Operatórias/epidemiologia
Desenho de Prótese/tendências
Melhoria de Qualidade
Sistema de Registros/estatística & dados numéricos
Medição de Risco
Índice de Gravidade de Doença
Substituição da Valva Aórtica Transcateter/efeitos adversos
Substituição da Valva Aórtica Transcateter/instrumentação
Substituição da Valva Aórtica Transcateter/métodos
Substituição da Valva Aórtica Transcateter/estatística & dados numéricos
[Pt] Tipo de publicação:JOURNAL ARTICLE; MULTICENTER STUDY
[Em] Mês de entrada:1712
[Cu] Atualização por classe:171205
[Lr] Data última revisão:
171205
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:171202
[St] Status:MEDLINE


  10 / 7835 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28987428
[Au] Autor:Simon EM; Summers SM
[Ad] Endereço:Emergency Department, San Antonio Uniformed Services Health Education Consortium, San Antonio Military Medical Center, SAMMC, MCHE-EMR, 3551 Roger Brooke Drive, JBSA Fort Sam Houston, TX 78234-6200, USA. Electronic address: emsimon85@gmail.com.
[Ti] Título:Vascular Access Complications: An Emergency Medicine Approach.
[So] Source:Emerg Med Clin North Am;35(4):771-788, 2017 Nov.
[Is] ISSN:1558-0539
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Millions of central venous and arterial catheters are placed across the United States annually as mechanisms of obtaining advanced hemodynamic monitoring and facilitating acute resuscitation. Although presumably life saving or sustaining in many circumstances, current literature identifies the preprocedural and postprocedural complications of infection, thrombosis, embolism, and iatrogenic injury as resulting in patient morbidity and mortality. Today, through the application of aseptic technique, performance of operator training, and the utilization of ultrasound, emergency physicians may limit vascular access complications and improve patient outcomes.
[Mh] Termos MeSH primário: Cateterismo Periférico/efeitos adversos
Medicina de Emergência/métodos
Dispositivos de Acesso Vascular/efeitos adversos
[Mh] Termos MeSH secundário: Cateterismo Periférico/instrumentação
Falha de Equipamento
Seres Humanos
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171012
[Lr] Data última revisão:
171012
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171009
[St] Status:MEDLINE



página 1 de 784 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde